Wilfredo De Jesus-Monge, M.D., M.S., is a physician-scientist with strong clinical research conduct, regulatory, and management experience, having occupied almost all roles in site study operations, including clinical research coordinator, blinded rater, chair, director, chief, sub-investigator, and principal investigator. He was recently recognized as 2023 Gold Clinical Researcher of the Year – The Americas by PharmaTimes Magazine and is a successful grant writer, earning funding from the American Cancer Society, St. Baldrick's Foundation, and Boehringer Ingelheim, among other organizations. Dr. De Jesus-Monge's clinical research work and experience have made him a sought-after speaker and panelist at national clinical research events. He is the author of 17 peer-reviewed journal articles, three book chapters, and over 90 abstracts for presentations at local, national, and/or international scientific meetings.